Display Settings:

Format

Send to:

Choose Destination
    Breast Cancer Res. 2007;9(3):107.

    Estrogen receptor-beta: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer?

    Abstract

    In the previous issue of the journal, Lin and coworkers present data demonstrate that increased expression of estrogen receptor (ER)-beta in ER-alpha-positive breast cancer cells antagonizes a defined group of ER-alpha/estrogen stimulated genes that are involved in cell cycle regulation and DNA replication. Similar expression patterns for these genes were found human ER-alpha positive breast tumors expressing higher levels or ER-beta, and this correlated with better clinical outcome. The implications for these data, which suggest that ER-beta is a positive actor and diagnostic marker for therapeutic outcome, are discussed.

    PMID:
    17617929
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1929104
    Free PMC Article

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk